Table 6.

Pain management in women undergoing CPC vs. ERAS in minimally invasive non-hysterectomy procedures

Pain Medication Use	CPC (n=214)	ERAS (n=196)	P-value
Narcotics (OME)
Pre-operative	0.0 0.0	28.3 7.6	*
Intra-operative	95.3 36.8	2.4 8.5	<.001
PACU	56.9 36.4	23.0 16.7	<.001
Total	152.2 57.1	55.3 21.1	<.001
Non-narcotic Pain Medications
Pre-operative	n=46/214 (21.5)	n=193/196 (98.5)	<.001
NSAID	36 (16.8)	154 (78.6)	<.001
Acetaminophen	14 (6.5)	192 (98.0)	<.001
Intra-operative	n=175/214 (81.8)	n=6/196 (3.1)	<.001
NSAID	79 (36.9)	4 (2.0)	<.001
Acetaminophen	156 (72.9)	2 (1.0)	<.001
PACU	n=69/214 (32.2)	n=177/196 (90.3)	<.001
NSAID	45 (21.0)	162 (82.7)	<.001
Acetaminophen	47 (22.0)	146 (74.5)	<.001
Non-narcotic Doses
Total	1.76 0.9	3.37 0.9	<.001

CPC, conventional peri-operative care; ERAS, enhanced recovery after surgery; PACU, post-anesthesia care unit; OME, oral morphine equivalents; NSAID, non-steroidal anti-inflammatory drugs

Data are n (%) or mean ± standard deviation

^*No statistical analysis possible given no standard preoperative narcotic administration in the CPC group